Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H13NO2 |
Molecular Weight | 191.2264 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
Stereo Comments | Assumed E; MM2 minimum energies of E and Z were -2.8973 and 2.1467/ 1.3201 kcal/mol respectively. |
SHOW SMILES / InChI
SMILES
OCCNC(=O)\C=C\C1=CC=CC=C1
InChI
InChIKey=OSCTXCOERRNGLW-VOTSOKGWSA-N
InChI=1S/C11H13NO2/c13-9-8-12-11(14)7-6-10-4-2-1-3-5-10/h1-7,13H,8-9H2,(H,12,14)/b7-6+
Molecular Formula | C11H13NO2 |
Molecular Weight | 191.2264 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3985591Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/idrocilamide.html | https://www.ncbi.nlm.nih.gov/pubmed/2140002 | https://www.ncbi.nlm.nih.gov/pubmed/8180884 | https://www.ncbi.nlm.nih.gov/pubmed/8012322
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3985591
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/idrocilamide.html | https://www.ncbi.nlm.nih.gov/pubmed/2140002 | https://www.ncbi.nlm.nih.gov/pubmed/8180884 | https://www.ncbi.nlm.nih.gov/pubmed/8012322
Idrocilamide (trade names Talval, Srilane, Relaxnova, Brolitène) is a medication with skeletal muscle relaxant[2] and anti-inflammatory actions used as a topical cream to treat lumbago and other kinds of muscular pain. Idrocilamide acts intracellularly by decreasing sarcoplasmic reticulum calcium release and externally by facilitating the voltage-dependent inactivation of the voltage sensor for excitation-contraction coupling. Idrocilamide has been reported to be a potent inhibitor of the metabolism of caffeine. Idrocilamide is available on prescription or over-the-counter in France and various other countries. Idrocilamide exerts a direct depressant effect on mechanical tension in rat soleus muscle fibers.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0014808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8180884 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Talval Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3985591
Single administration - 60 mg
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8180884
Experiments were performed at 37C on small bundles (5- 15 fibers) isolated from sealeus nrauscles of female Wistar rats. Before each set of experiments, the preparations were stimulated in the control solution during 20 min or more tea check for viability (those bundles exhibiting progressive decrease in twitch amplitude were discarded). Caffeine contrackres were elicited by application of caffeine added to the bathing medium to give a final concentration of 6 mkM. Such a caffeine concentration permitted repetitive contractures without damaging fibers After the initial equilibrating perid, the sensitivity of bundles for 6 mkM caffeine was checked two times, separated by a 30-min interval in which caffeine was absent. Only bundles that exhibited two successive contractures of equal amplitude were further tested with LCB29 (Idrocilamide).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:28:23 GMT 2023
by
admin
on
Fri Dec 15 15:28:23 GMT 2023
|
Record UNII |
6C816LUB1O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM02AX05
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
||
|
NCI_THESAURUS |
C29696
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
||
|
WHO-ATC |
M02AX05
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
44979
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
58207
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
3547
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
230-155-1
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
63229
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
C74280
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
19729
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB08121MIG
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
1418
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
DTXSID8046404
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
1550874
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
35241-61-3
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
ALTERNATIVE | |||
|
DB13297
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
6961-46-2
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL102358
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
Idrocilamide
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
100000083679
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | |||
|
m6203
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
6C816LUB1O
Created by
admin on Fri Dec 15 15:28:23 GMT 2023 , Edited by admin on Fri Dec 15 15:28:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |